RE Rapid Antigen assays8 May 2020 22:46
Anyone basing Avacta share price or future share price should I say on this rapid, obviously hasn't researched the company very much at all. It's Avacta's breakthrough in cancer treatments that will determine it's future. The 100 billion a year cancer treatment business I'm talking about, the patented preCISION delivery system developed by Avacta is the biggest game changer in oncology treatments for a decade. So those claiming to have researched the company and blah blah blah, not to have even mentioned this, clearly are talking bulls**t